These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32793226)

  • 21. On the mark: genetically engineered immunotherapies for autoimmunity.
    Ellebrecht CT; Lundgren DK; Payne AS
    Curr Opin Immunol; 2019 Dec; 61():69-73. PubMed ID: 31563849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune therapy for autoimmune diseases.
    Steinman L
    Science; 2004 Jul; 305(5681):212-6. PubMed ID: 15247472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in autoimmune liver diseases.
    Manns MP
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):575-7. PubMed ID: 8836203
    [No Abstract]   [Full Text] [Related]  

  • 24. Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.
    Sauer EL; Cloake NC; Greer JM
    Int Rev Immunol; 2015; 34(6):460-85. PubMed ID: 25970132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells: cellular mediators for immunological tolerance.
    Chung CY; Ysebaert D; Berneman ZN; Cools N
    Clin Dev Immunol; 2013; 2013():972865. PubMed ID: 23762100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the pathogenesis of autoimmune disease: recent advances at the molecular level and relevance to oral mucosal disease.
    Jonsson R; Mountz J; Koopman W
    J Oral Pathol Med; 1990 Sep; 19(8):341-50. PubMed ID: 2250224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
    Miller SD; Turley DM; Podojil JR
    Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
    Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
    Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmet challenges in immune-mediated hepatobiliary diseases.
    Beuers U; Gershwin ME
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):127-31. PubMed ID: 25820618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of autoimmunity in human diseases: a critical review of current dogma.
    Benson RA; Brewer JM; Platt AM
    Curr Opin Rheumatol; 2014 Mar; 26(2):197-203. PubMed ID: 24445477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting-edge issues in organ-specific autoimmunity.
    Gershwin ME; Shoenfeld Y
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):123-5. PubMed ID: 21887609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring tolerance with antigen delivery.
    Jabri B; Abadie V
    Science; 2024 Jan; 383(6678):30-32. PubMed ID: 38175899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of dendritic cells in the induction and maintenance of autoimmune diseases.
    Ludewig B; Odermatt B; Ochsenbein AF; Zinkernagel RM; Hengartner H
    Immunol Rev; 1999 Jun; 169():45-54. PubMed ID: 10450507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
    Torres-Aguilar H; Sosa-Luis SA; Ríos-Ríos WJ; Romero-Tlalolini MLÁ; Aguilar-Ruiz SR
    Autoimmunity; 2020 Nov; 53(7):367-375. PubMed ID: 32815426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lymphoid liver: considerations on pathways to autoimmune injury.
    Kita H; Mackay IR; Van De Water J; Gershwin ME
    Gastroenterology; 2001 May; 120(6):1485-501. PubMed ID: 11313320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
    Coleman MA; Steptoe RJ
    Autoimmun Rev; 2012 Dec; 12(2):195-203. PubMed ID: 23047179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific therapy for autoimmune disease.
    Harrison LC; Hafler DA
    Curr Opin Immunol; 2000 Dec; 12(6):704-11. PubMed ID: 11102776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.
    Bogdanos DP; Dalekos GN
    Curr Med Chem; 2008; 15(22):2285-92. PubMed ID: 18781950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.
    Hartwell BL; Pickens CJ; Leon M; Northrup L; Christopher MA; Griffin JD; Martinez-Becerra F; Berkland C
    J Autoimmun; 2018 Sep; 93():76-88. PubMed ID: 30007842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in autoimmune liver diseases.
    Manns MP
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S256-71. PubMed ID: 9407346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.